miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma

[1]  Dongshan Zhang,et al.  MBD2 as a Potential Novel Biomarker for Identifying Severe Asthma With Different Endotypes , 2021, Frontiers in Medicine.

[2]  Tao Li,et al.  IL‐17A‐producing T cells exacerbate fine particulate matter‐induced lung inflammation and fibrosis by inhibiting PI3K/Akt/mTOR‐mediated autophagy , 2020, Journal of cellular and molecular medicine.

[3]  T. Nabe.  Steroid-Resistant Asthma and Neutrophils. , 2020, Biological & pharmaceutical bulletin.

[4]  M. Sanak,et al.  Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration , 2019, Clinical and Translational Allergy.

[5]  C. Saltoun,et al.  Classification of asthma. , 2019, Allergy and Asthma Proceedings.

[6]  C. Akdis,et al.  microRNA‐146a is linked to the production of IgE in mice but not in atopic dermatitis patients , 2018, Allergy.

[7]  F. E. Lee,et al.  Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease , 2018, Clinical Reviews in Allergy & Immunology.

[8]  X. Xiang,et al.  MBD2 regulates differentiation and function of Th17 cells in neutrophils- dominant asthma via HIF-1α , 2018, Journal of Inflammation.

[9]  E. Bleecker,et al.  Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma , 2018, Science Immunology.

[10]  A. Kho,et al.  Circulating microRNAs and prediction of asthma exacerbation in childhood asthma , 2018, Respiratory Research.

[11]  James T. Elder,et al.  miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis. , 2017, The Journal of investigative dermatology.

[12]  Dongshan Zhang,et al.  MBD2 Regulates Th17 Cell Differentiation and Experimental Severe Asthma by Affecting IRF4 Expression , 2017, Mediators of inflammation.

[13]  Huahao Shen,et al.  Comparison of the roles of house dust mite allergens, ovalbumin and lipopolysaccharides in the sensitization of mice to establish a model of severe neutrophilic asthma , 2017, Experimental and therapeutic medicine.

[14]  I. Adcock,et al.  MicroRNA‐21 drives severe, steroid‐insensitive experimental asthma by amplifying phosphoinositide 3‐kinase–mediated suppression of histone deacetylase 2 , 2017, The Journal of allergy and clinical immunology.

[15]  P. Nikamo,et al.  MicroRNA‐146a suppresses IL‐17–mediated skin inflammation and is genetically associated with psoriasis , 2017, The Journal of allergy and clinical immunology.

[16]  Z. Yao,et al.  Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling , 2016, Molecular Neurobiology.

[17]  T. Akiyama,et al.  The RNA Binding Protein Mex-3B Is Required for IL-33 Induction in the Development of Allergic Airway Inflammation. , 2016, Cell reports.

[18]  K. Baines,et al.  A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro , 2016, Thorax.

[19]  Zhaolan Zhou,et al.  Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation , 2016, Front. Genet..

[20]  Rakesh K. Kumar,et al.  Using multiple online databases to help identify microRNAs regulating the airway epithelial cell response to a virus‐like stimulus , 2015, Respirology.

[21]  K. Ansel,et al.  MicroRNA regulation of allergic inflammation and asthma. , 2015, Current opinion in immunology.

[22]  P. Pfeffer,et al.  Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol , 2015, The Journal of allergy and clinical immunology.

[23]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[24]  S. Clark,et al.  Methyl-CpG-binding domain proteins: readers of the epigenome. , 2015, Epigenomics.

[25]  Y. Bossé,et al.  MicroRNA‐19a enhances proliferation of bronchial epithelial cells by targeting TGFβR2 gene in severe asthma , 2015, Allergy.

[26]  Rakesh K. Kumar,et al.  MicroRNA: Potential biomarkers and therapeutic targets for allergic asthma? , 2014, Annals of medicine.

[27]  A. Halayko,et al.  MicroRNA-146a and microRNA-146b expression and anti-inflammatory function in human airway smooth muscle. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[28]  C. Akdis,et al.  MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. , 2014, The Journal of allergy and clinical immunology.

[29]  L. Wen,et al.  MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis. , 2014, Journal of autoimmunity.

[30]  A. Pivarcsi,et al.  MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. , 2014, The Journal of investigative dermatology.

[31]  A. Bossios,et al.  MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung. , 2014, The Journal of allergy and clinical immunology.

[32]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[33]  Wu-xian Li,et al.  Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. , 2012, Translational research : the journal of laboratory and clinical medicine.

[34]  Manish Kumar,et al.  Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model. , 2012, Journal of applied physiology.

[35]  Ankur Kulshreshtha,et al.  Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. , 2011, The Journal of allergy and clinical immunology.

[36]  S. Orkin,et al.  MicroRNA-21 Limits In Vivo Immune Response-Mediated Activation of the IL-12/IFN-γ Pathway, Th1 Polarization, and the Severity of Delayed-Type Hypersensitivity , 2011, The Journal of Immunology.

[37]  P. Foster,et al.  Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. , 2011, The Journal of allergy and clinical immunology.

[38]  R. Medzhitov,et al.  Abnormal Trafficking and Degradation of TLR4 Underlie the Elevated Inflammatory Response in Cystic Fibrosis , 2011, The Journal of Immunology.

[39]  Rakesh K. Kumar,et al.  Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target , 2011, BMC pulmonary medicine.

[40]  P. Geurts,et al.  MicroRNAs Profiling in Murine Models of Acute and Chronic Asthma: A Relationship with mRNAs Targets , 2011, PloS one.

[41]  S. Phipps,et al.  Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease , 2009, Proceedings of the National Academy of Sciences.

[42]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[43]  J. Alcorn,et al.  TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice1 , 2008, The Journal of Immunology.

[44]  M. Lindsay,et al.  Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells1 , 2008, The Journal of Immunology.

[45]  M. Lindsay,et al.  Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids , 2007, BMC Genomics.

[46]  L. Borish.  Allergic rhinitis: systemic inflammation and implications for management. , 2003, The Journal of allergy and clinical immunology.

[47]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.